VDI Laboratory

VDI is the leading provider of diagnostic testing in support of Integrative Veterinary Medicine in the fields of cancer, GI disease, atopy, dietary evaluation, disease screening, and other specialty applications.

About VDI Laboratory

Veterinary Diagnostics Institute (VDI) was originally founded in 2006 with a singular mission: to make advanced diagnostics, developed for humans, available to companion animals, thereby enhancing the diagnostic capabilities of veterinarians.

Today, there is a growing demand from pet parents for better care and disease prevention through a more natural organic approach using fresh or raw diets, avoiding surgery when possible, and a non-pharmacological approach. Whereas, traditional veterinary medicine primarily focuses on treating symptoms with pharmaceuticals and surgery, integrative veterinary medicine combines these conventional methods with holistic approaches to address root causes and promote overall wellness.

VDI is dedicated to supporting integrative care by helping veterinarians identify deficiencies or metabolic abnormalities to prevent disease and diagnose the root causes of illnesses. Our comprehensive testing services now encompass blood, fur, urine, and stool analyses in areas such as cancer, GI disease, atopy, endocrine disorders, degenerative joint disease, dietary evaluation, and disease screening for early detection and prevention.

High Complexity testing machine used by VDI Laboratory

Company Timeline

2024 – Current Year

LAUNCH:

  • Atopic dermatitis and Infection Panel for cats & dogs
  • Insulin test
  • Insulin Resistance Panel

DEVELOPMENT:

  • In progress pipelines in the areas of Cancer, GI Disease, and Sample Logistics

PARTNERSHIPS:

  • Initiated testing partnership with Hormonalle Laboratory in Brasil.
  • Initiated testing partnership with CEDIVEP Laboratory in Paraguay
2023 – Laboratory Move & New Services

LAUNCH:

  • Glyphosate Panel for cats & dogs
  • GI Microbiome Panel for cats & dogs

CORPORATE MOVE:

  • VDI moved to a new building as our growth necessitated a larger lab space. The new building affords us the space needed to continue to add new testing, new equipment, and new personnel.

PARTNERSHIPS:

  • Initiated testing partnership with GreenVet Laboratory in South Korea.
  • Initiated testing partnership with MiDog® for NGS Microbiome Testing
  • Initiated testing partnership with EasyDNA for UK & Germany pet parents
2022 – Menu expansion & new partnerships

LAUNCH:

  • GI Lymphoma Panel for dogs
  • Advanced GI Panel
  • Chronic Enteropathy Panel
  • Pancreatitis Monitoring Panel
  • cPL/fPL
  • Cortisol
  • Cancer Panel- Lymphoma
  • Fur Mineral Analysis
  • Allergy Panel
  • Allergic Dermatitis Panel
  • Hyaluronic Acid test, Osteoarthritis panel for felines
  • Cancer Risk Assessment, Complete Wellness Panel for felines

INTRODUCED:

  • Test n’ Treat for Joint Health with Hyaluronic Acid/TrixSyn

PARTNERSHIPS:

  • Initiated partnership with Cogent Solutions for integration of joint supplement Trixsyn
  • Initiated testing partnership with Delta Biomarkers SAS in France
2021 – Improvement on existing services

LAUNCH:

  • CRP/Albumin Ratio (CAR) for disease severity prognosis

INTRODUCED:

  • AgaricusBio product for cancer support
2020 – Menu expansion & new partnerships

LAUNCH:

  • Vitamin D Toxicity Panel
  • Folate
  • Feline GI Lymphoma Panel

INTRODUCED:

  • Magnesium Lotion For Pets – topical supplement for correcting low magnesium levels.

PARTNERSHIPS:

  • Initiated partnership with MagnumSolace for sale of Magnesium Lotion
2019 – Menu Expansion & Rebranding of tests

LAUNCH:

  • Vitamin B12
  • Magnesium
  • Chem12
  • Hyaluronic Acid (Joint Test)
  • Osteoarthritis Panel
  • Pericardial Effusion Panel
  • Pre-Stem Cell Therapy Panel

RENAMING:

  • Renamed INCaSe to Cancer Risk Assessment
  • Relaunched test menu with new test names
  • Application-specific panels

PARTNERSHIPS:

  • Initiated partnership with Neodin Biovet for test distribution in South Korea.
2018 – Launch of Dry Specimen Technology

LAUNCH:

  • Dry Serum Test Kits – Patented technology Samplla® for stabilizing fluid samples for extended periods of time.

PARTNERSHIPS:

  • Expanded partnership with Rx Vitamins for distribution of full Rx Vitamins product line.
2017 – Menu expansion and R&D

LAUNCH:

  • TK-Equine: Blood test for the determination of lymphoma in horses

PARTNERSHIPS:

  • Initiated partnership with Kepler Diagnostics to develop Samplla® technology.
2016 – Company reorganization

REORGANIZATION:

  • Reorganized company with Veterinary Diagnostics Institute becoming parent company to VDI Laboratory (VDI) – The new customer facing name for the specialty lab.

2015 – First Dry Specimen Kit

LAUNCH:

  • Launch of the Vitamin D Spot Saver Kit – the first VDI blood test using a commercially available dry specimen transport method known as Dried Blood Spot (DBS) card.

2014 – Partnership & Test n’ Treat

LAUNCH:

  • Calcemia Panel for determining cause of hyper/hypocalcemia
  • First Test n’ Treat service with Vitamin D test & Vitamin D3 supplement

PARTNERSHIPS:

  • Initiated partnership with Rx Vitamins for Pets for Vitamin D3 supplementation.

2013 – Menu Expansion

LAUNCH:

  • TK-Feline+ Cancer Panel: the first two-biomarker cancer blood test for cats on the market
  • Vitamin D test – the new gold standard for cats and dogs

2012 – Menu Expansion

LAUNCH:

  • TK-Canine+ Cancer Panel: the first two-biomarker cancer blood test for dogs on the market
  • INCaSe (Initial Notification Cancer Screening) for dogs: The first true screening blood test for cancer in dogs

2010 – New Partnership

PARTNERSHIPS:

  • Initiated partnership with Webster Vet Supply (now Patterson Vet Supply) for distribution of services

2009 – New Tests

LAUNCH:

  • VDI-TKcanine: The first blood test on the market for diagnosing and monitoring tumor activity in dogs
  • VDI-TKfeline: The first blood test on the market for diagnosing and monitoring tumor activity in cats

2008 – Transitions

TRANSITIONS:

  • Veterinary Diagnostics Institute (VDxI) sells CardioCare to IDEXX, which is now being sold as CardioPet.
  • VDI begins transition from cardiac disease to focus on cancer testing.

2006 – Founding

FOUNDING:

  • Veterinary Diagnostics Institute (VDxI) is Founded

LAUNCH:

  • CardioCare, NT-proBNP marker: a blood test for cardiac disease in dogs and cats